Showing posts with label Hospital Market Singapore. Show all posts
Showing posts with label Hospital Market Singapore. Show all posts

Friday, September 28, 2018

Rising Demand Of Healthcare In Singapore Market Outlook: Ken Research


With the growing concern related to health the healthcare industry is growing more significantly and make this a billionaire market. Moreover, in this industry the technology is developed more significantly as with the help of technology the dangerous diseases can be identified and several related tests could be done. According to the report analysis, ‘Singapore Healthcare Market Forecast To 2022 – By Type Of Clinics (Medical And Dental), By Hospitals (Private, Public And Not-For-Profit), By Prescription And Otc Drugs, By Type Of Medical Devices (Consumables, Diagnostic Imaging, Patient Aids, Orthopedics & Prosthetics, Dental Products And Others)states that Singapore healthcare market is driven by hospital sectors and clinics on the back of improvement in healthcare services and medical tourism. Whereas, Singapore has one of the latest health infrastructure across the globe and due to the aging population and medical tourism the demand for healthcare services will drive in a more significant manner. Most of the costly tertiary health care facilities are served by public medical institutes at reasonable prices whereas, this is enabled by the establishment of MediShield Life which is the National Health Insurance Scheme.

The market of Singapore Hospitals is increased at a declining rate at the period of 2012-2017 whereas, the Macro trends are significantly affecting this market which including rising chronic disease prevalence, ageing population, escalating healthcare needs and several others. The Acute hospitals have accounted for handsome amount of share in the number of hospitals and huge proportion of beds in 2017 followed by psychiatric hospitals and community. Moreover, the Singapore clinics market increased at a significant CAGR at the review period and the industry is at a nascent stage of growing more significantly with the major clinic group’s enterprise inorganic methods of enlarging and surging their facilities portfolio. In the overall revenue generation the medical clinics have accounted for the highest share in Singapore in 2017 which is majorly operated by organic and inorganic expansions of huge number of players and agreement of light asset model.
On the regional basis, the central region by high population and greater connectivity with the other sectors of Singapore had driven the largest number of clinics in Singapore in 2017. Whereas the Northern region has accounted robust concentration of number of clinics in Singapore in 2017 moreover, Woodlands and Yishun have handsome number of clinics which are offering family medicine and dental. Furthermore, northern region is followed by west region, south region and east region.

Singapore Medical Groups, Q&M Dental Group, Singapore General Hospital, Changi General Hospital, GSK, Singapore, Beacon Pharmaceuticals, Guardian Pharmacy, Unity Pharmacy, Singapore Clinical Research Institute, QT Vascular, Biosensors International, National Healthcare Group Diagnostics, Innovative Diagnostics and Radlink are the major companies which are currently functioning more actively in this market and make the market more competitive and attractive which will further attract so many investor which will are support this market financially and effective initiative in the framework of working. Moreover, many of the key players are benefitted with the partnerships, mergers and acquisitions and others which are more helpful in expanding their business profile and status. Therefore, in the coming years it is expected that the Singapore healthcare market will grow in the coming years with the more development in the technology of medicine making and establishment of new clinics over the decades.

Keywords Covered in this report:- Pharmaceutical Market Singapore,  Clinics Market Singapore, Contract Research Organization (CRO) Market Singapore, Medical Devices Market Singapore, Healthcare Spending Singapore, Indonesia Healthcare Singapore, Diabetes Prevalence Singapore, Singapore Pharmaceutical Future, Clinics Future Trends Singapore, Number of Pharmacies Singapore, Number of Hospitals Singapore, Type of Medical Devices Singapore, Type of Clinical Laboratory Singapore, Number of Clinical Laboratories Singapore, Number of Clinics Singapore

For more information about the publication, refer to below link:-

Related Reports:-



Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Friday, August 31, 2018

Singapore Healthcare Market Forecast to 2022-Ken Research


The report titled “Singapore Healthcare Market Forecast to 2022 - by Type of Clinics (Medical and Dental), by Hospitals (Private, Public and Not-for-Profit), by Prescription and OTC Drugs, by type of Medical Devices (Consumables, Diagnostic Imaging, Patient Aids, Orthopedics & Prosthetics, Dental Products and Others)provides information on market size for Singapore hospital, pharmaceutical, pharmacy retail, clinics, Contract Research Organization and medical devices. The report covers aspects such as, hospital market segment (by public, private & not-for-profit hospitals, by Inpatient & Outpatient and by Acute, Community & Psychiatry Hospitals), pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), pharmacy retail market segment (by drugs & private label goods and by region), CRO market segmentation (by Therapeutic Class & by Clinical Trial Phase) and medical device market segment (by type of medical device, and by end user), competitive landscape of major players in the Singapore clinics market, hospital market, pharmaceutical market, pharmacy retail market, clinical laboratory market, CRO market and medical devices market and covering competitive landscape of major healthcare institutions including Singapore Medical group, Q&M Dental Group, Singapore General Hospital, Ferrer Park, Changi General Hospital, GSK, Singapore, Beacon pharmaceuticals, Guardian Pharmacy, Unity Pharmacy, Singapore Clinical Research Institute, QT Vascular, Biosensors International, National Healthcare Group Diagnostics, Innovative Diagnostics and Radlink. The report concludes with market projections for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore Healthcare Market Overview
Singapore has one of the best health infrastructures in the world. The population is ageing and medical tourism will drive the demand for healthcare services in Singapore in the near future. Most of the expensive tertiary care services are provided by public hospitals at affordable rates. This is supported by the implementation of MediShield Life which is the National Health Insurance Scheme. Primary healthcare services are mostly provided by private sector practitioners and some by government polyclinics operating under MOH. Public hospitals and specialty centers engage in clinical research.

Market Segmentation
Singapore Hospital Market
Singapore hospitals market increased at a declining rate during 2012-2017. Macro trends positively affecting the hospital market include ageing population, rising chronic disease prevalence, escalating healthcare needs and increasing complexity of care needs.
Revenue from outpatients have accounted for the major share in Singapore hospital market in 2017 followed by revenue generated from inpatient services. This was majorly due to shift in focus towards preventive healthcare services which augmented the revenues from outpatient services.
Acute hospitals have accounted for majority share in the number of hospitals and largest proportion of beds in 2017 followed by Community and psychiatric hospitals.

Singapore Clinics Market
Singapore clinics market increased at a positive CAGR during the review period. The market is at a growing stage with major clinic groups undertaking inorganic methods of expansion and widening their service portfolio.

Medical clinics have accounted for the largest share in the overall revenue generated by clinics in Singapore in 2017. This is majorly driven by organic and inorganic expansion of large players and adoption of asset light model. Other major types of clinics include dental clinics.
The central region of Singapore has accounted for the largest number of the clinics in Singapore in 2017 driven by high population, and greater connectivity with other parts of Singapore. The north region has registered robust concentration of number of clinics in Singapore in 2017. Within this region, Woodlands and Yishun have most number of clinics offering dental and family medicine. This is followed by east region, west region and south region.

Singapore Pharmaceutical Market
Singapore Pharmaceutical market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research and access to regional markets and skilled workforce. Singapore Pharmaceutical market has registered an increase in the revenue at a positive CAGR during 2012-2017.
Prescription drugs have accounted for the largest share in the revenue in Singapore pharmaceutical market in 2017 driven by new brands, high prices for existing drugs and fewer patent expiries. OTC drugs have accounted for the remaining share of the revenue owing to rise in trend of self-medication in Singapore.
Patented drugs have accounted for largest share in the revenue in Singapore prescription drugs market in 2017. Generic drugs have accounted for the remaining share of the revenue.

Singapore Pharmacy Retail Market
Singapore pharmacy retail market revenue has escalated at a positive CAGR during 2012-2017.
Private Label Goods have registered the largest share in the revenue share in Singapore pharmacy retail market 2017. Drugs have accounted for the remaining share in 2017. The sale of prescription drug in Singapore is not high as the doctor is allowed to sell those drugs at cheaper costs.
Central Region has accounted for the largest number of the pharmacies in Singapore in 2017 due to the presence of large number of hospitals and clinics and supported by high population. This is followed by north, east, west and south Singapore.

Singapore Medical Device Market
Singapore Medical device market is in the growing stage with rise in number of foreign players.
Medical Consumables have accounted for the largest share in the revenue generated by medical device market in Singapore in 2017. This is followed by diagnostic imaging products, patient’s aids, orthopedic & prosthetics, dental products. Others include Point of Care Testing devices, radiation oncology devices, therapy system and testing and measurement systems.

Ministry of Health which controls most of the hospitals and significant proportion of the clinics in Singapore has accounted for largest share in the revenue generated by medical devices in Singapore in 2017. Other healthcare institutions such as private hospitals and clinical laboratories have accounted for the remaining share.

Key Topics Covered in the Report:-
·         Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO  Market Size, 2012-2017
·         Singapore Hospitals Market Segmentation (by Public, Private Hospital & Not-for-Profit Hospital, by Inpatient & Outpatient, by Acute, Community & Psychiatry Hospitals)
·         Singapore Clinics Market Segmentation (By Type Of Clinic And By Region)
·         Singapore Medical Device Market Segmentation (By Type Of Medical Device, And By End User)
·         Singapore Pharmaceutical Market Segmentation (by Prescription & OTC Drugs, by Patented & Generic Drugs)
·         Singapore Pharmacy Retail Market Segmentation (by Drugs & Private Label Goods and By Region)
·         Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO  Market Competitive Landscape
·         Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO  Market Future Outlook and Projections, 2018-2022
·         Analyst Recommendations

For more information about the publication, refer to below link:-

Related Reports:-



Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications

Sales@kenresearch.com
+91-9015378249

Friday, June 29, 2018

Singapore Hospital Market Outlook to 2022-Ken Research


The report titled “Singapore Hospital Market Outlook to 2022 - by Public, Private Hospital & not-for-Profit Hospital, by Inpatient & Outpatient, by Acute, Community & Psychiatry Hospitalsprovides information on market size for Singapore hospital. The report covers aspects such as hospital market segment (by public, private & not-for-profit hospitals, by Inpatient & Outpatient and by Acute, Community & Psychiatry Hospitals), competitive landscape of major players in the Singapore hospital market including Singapore General Hospital, KK Women’s and Children Hospital, Bright Vision Hospital, Changi general hospital, Raffles Medical group, Tan Tock Seng Hospital, Institute of Mental Health, Yishun Community Hospital, Khoo Teck Puat Hospital, IHH healthcare Berhad, and Raffles Medical Group. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Singapore Hospital Market Overview
Singapore hospitals market increased at a declining rate during 2012-2017. Macro trends positively affecting the hospital market include ageing population, rising chronic disease prevalence, escalating healthcare needs and increasing complexity of care needs. The growth slowdown was majorly due to slowdown in medical tourism. Backed by greater demand, major hospitals have invested in expansion strategies. For instance, IHH Healthcare witnessed positive growth in revenue due to ramp up of Mount Elizabeth Novena Hospital as the hospital added 30 beds. The market witnessed higher inpatient admissions, improvement in average revenue per inpatient admission due to higher complexity of medical conditions.

Market Segmentation
By Inpatient and Outpatient: Revenue from outpatients have accounted for the majority share in Singapore hospital market in 2017. Rest was generated from inpatient services. This was majorly due to shift in focus towards preventive healthcare services which augmented the revenues from outpatient services.

By Public, Private & not-for-Profit Hospitals: Most of the hospitals in Singapore are owned and managed by the public sector. Public hospitals have also accounted for the larger share of hospitals beds in Singapore in 2017. Rest of the hospitals are owned and managed by the private sector and not for profit organizations. Public & private hospitals offer specialized and integrated services whereas not-for-profit hospitals offer rehabilitative care and palliative care services.

By Acute, Community & Psychiatric Hospitals: Acute hospitals have accounted for the majority share in the number of hospitals and number of beds in 2017. Rest of the hospitals comprise of community and psychiatric hospitals.

Competition Overview
The hospitals in Singapore are controlled by the public sector, private sector and not-for-profit organizations. Private hospitals come under high value, low volume category (high fees, lower occupancy) whereas public hospitals come under high volume, low value category (low fees, higher occupancy). Public hospitals are more dedicated towards serving mass population whereas private hospitals are more inclined towards affluent class and medical tourists. Major hospitals include including Singapore General Hospital, KK Women’s and Children Hospital, Bright Vision Hospital, Changi general hospital, Raffles Medical group, Tan Tock Seng Hospital, Institute of Mental Health, Yishun Community Hospital, Khoo Teck Puat Hospital, IHH healthcare Berhad, and Raffles Medical Group. Major competition parameters for private hospitals are facilities, number of beds, number of hospitals, fees, quality of doctors/medical practitioners and specialization.

Future Potential
The hospitals market in Singapore is expected to grow at a positive CAGR during 2017-2022. Singapore hospitals market will be driven by organic expansion of both public and private hospitals and increased government initiatives in the healthcare sector to provide better care to the geriatric population. For instance, Tan Tock Seng Hospital will open new 300 bed infectious disease hospital by 2018 act as a containment facility in the event of an outbreak similar to the severe acute respiratory syndrome (Sars). Further, the government has revealed expansion plans for Singapore General Hospital which includes opening of Outram Community Hospital by 2020, National Cancer Centre Singapore (NCCS) by 2040, expansion of SGH Accident & Emergency (A&E) Block. Further, rising competition in the industry may lead major players to undertake mergers and acquisitions which could drive the industry towards consolidation.

For more information on the research report, refer to below link:

Related Reports by Ken Research:



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249